recombinant granulocyte macrophage colonystimulating factor (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
95
Structured Review
MedChemExpress
recombinant granulocyte macrophage colonystimulating factor
Recombinant Granulocyte Macrophage Colonystimulating Factor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm+csf/GM-CSF%2C+Mouse/pm42600954-108-18-24
Average 95 stars, based on 5 article reviews
Recombinant Granulocyte Macrophage Colonystimulating Factor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gm+csf/GM-CSF%2C+Mouse/pm42600954-108-18-24
Average 95 stars, based on 5 article reviews
recombinant granulocyte macrophage colonystimulating factor - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Isolation:Article Title: Light-promoted engineered bacterial DNase I therapeutic intervention to enable potent cancer photoimmunotherapy. Article Snippet: Bacteria are emerging as a promising tool for targeted cancer therapy due to their innate tumor-homing ability, high mobility, and capacity to rapidly colonize in the tumor microenvironment (TME).. However, bacterial cancer therapy (BCT) alone has not proven fully effective.. Herein, we present an innovative bio-therapeutic system, TEPy@VNP-D, which integrates genetically engineered Salmonella typhimurium VNP20009 carrying humanized DNase I toxin plasmids (VNP-D) with an aggregation-induced emission photosensitizer (TEPy), enabling photoimmunotherapy for melanoma. Red Blood Cell Lysis:Article Title: Light-promoted engineered bacterial DNase I therapeutic intervention to enable potent cancer photoimmunotherapy. Article Snippet: Bacteria are emerging as a promising tool for targeted cancer therapy due to their innate tumor-homing ability, high mobility, and capacity to rapidly colonize in the tumor microenvironment (TME).. However, bacterial cancer therapy (BCT) alone has not proven fully effective.. Herein, we present an innovative bio-therapeutic system, TEPy@VNP-D, which integrates genetically engineered Salmonella typhimurium VNP20009 carrying humanized DNase I toxin plasmids (VNP-D) with an aggregation-induced emission photosensitizer (TEPy), enabling photoimmunotherapy for melanoma. Cell Culture:Article Title: Light-promoted engineered bacterial DNase I therapeutic intervention to enable potent cancer photoimmunotherapy. Article Snippet: Bacteria are emerging as a promising tool for targeted cancer therapy due to their innate tumor-homing ability, high mobility, and capacity to rapidly colonize in the tumor microenvironment (TME).. However, bacterial cancer therapy (BCT) alone has not proven fully effective.. Herein, we present an innovative bio-therapeutic system, TEPy@VNP-D, which integrates genetically engineered Salmonella typhimurium VNP20009 carrying humanized DNase I toxin plasmids (VNP-D) with an aggregation-induced emission photosensitizer (TEPy), enabling photoimmunotherapy for melanoma. Article Title: Akkermansia muciniphila ‐derived hypoacylated rough‐type lipopolysaccharides alleviate diet‐induced obesity via activation of TLR4−IL‐23−IL‐22 immune axis Article Snippet: RAW264.7 cells purchased from ATCC was cultured with DMEM (6016121; Dakewe) supplemented with 10% FBS (RY‐F81‐05; Royacel) and 1% penicillin and streptomycin (MA0110; Meilunbio). .. The bone marrow cells were cultured in complete DMEM supplemented with Article Title: Escherichia coli J5-derived OMVs with hypoendotoxic LPS: Potential boosters of T-cell immunity and IL-17 production for enhanced vaccine efficacy. Article Snippet: Lipopolysaccharide (LPS) is the core epitope of Escherichia coli (E. coli) J5 (O111:B4), a vaccine strain for bovine mastitis.. It provides a significant protective effect in host suffering from Gram-negative bacteremia.. However, LPS remains the main toxin in bacterial outer membrane vesicles (OMVs), which are non-replicative nanoparticles capable of robust immune modulation. other:Article Title: Granulocyte-macrophage colony-stimulating factor at work: Promoting vascular maturation for accelerated wound healing. Article Snippet: EC only group: GM-CSF (HY-P7016, Article Title: Pan-cancer analysis reveals HDAC1 as a key regulator of immune infiltration and T cell exhaustion Article Snippet: Cells were suspended in PBS and differentiated into M0 macrophages using 20 ng/mL Suspension:Article Title: Escherichia coli J5-derived OMVs with hypoendotoxic LPS: Potential boosters of T-cell immunity and IL-17 production for enhanced vaccine efficacy. Article Snippet: Lipopolysaccharide (LPS) is the core epitope of Escherichia coli (E. coli) J5 (O111:B4), a vaccine strain for bovine mastitis.. It provides a significant protective effect in host suffering from Gram-negative bacteremia.. However, LPS remains the main toxin in bacterial outer membrane vesicles (OMVs), which are non-replicative nanoparticles capable of robust immune modulation. |